Lung Cancers Recruiting Phase 1 Trials for Ceritinib (DB09063)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02321501Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerTreatment
NCT03611738Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCTreatment